Michael O Johnson - 25 Feb 2026 Form 4/A - Amendment Insider Report for HERBALIFE LTD. (HLF)

Reporting relationship: Director, Executive Chairman
Issuer ticker: HLF
Reported as of: 25 Feb 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 03 Mar 2026, 21:26:42 UTC
Original report date: 27 Feb 2026
Prior SEC filing: 03 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Alaaeddine Sahibi, as Attorney-In-Fact for Michael O. Johnson

Key filing fact

Michael O Johnson filed Form 4/A - Amendment for HERBALIFE LTD. (HLF) on 03 Mar 2026.

Key facts

This page summarizes Michael O Johnson's Form 4/A - Amendment filing for HERBALIFE LTD. (HLF).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 21:26.

Change

Previous filing in this sequence was filed on 03 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001311173 Primary reporting owner

JOHNSON MICHAEL

Relationship: Director, Executive Chairman
Address: 800 WEST OLYMPIC BLVD., SUITE 406, LOS ANGELES
Signature: /s/ Alaaeddine Sahibi, as Attorney-In-Fact for Michael O. Johnson
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HLF transaction

Common Stock

Award

Transaction value: $0
Shares: +72,689
Change %: +8.9%
Price: $0.000000
Shares after: 887,415
Date: 25 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HLF transaction Derivative

Stock Appreciation Rights

Award

Transaction value: $0
Shares: +399,619
Change %
Price: $0.000000
Shares after: 399,619
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 399,619
Exercise price: $19.26
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan (the "Plan"). These RSUs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date.

Footnote F2

This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed.

Footnote F3

Consists of stock appreciation rights ("SARs") granted under the Plan. These SARs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date.